Observational studyMedicine2026
Global trends in gastric and colorectal cancer, 1990 to 2021: A population-based observational study using GBD 2021 data.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric and colorectal cancers are among the most prevalent gastrointestinal malignancies worldwide and represent significant global public health concerns. Their epidemiological profiles vary substantially across regions and sociodemographic contexts. Despite advances in screening and treatment, both types of cancer continue to cause considerable morbidity and mortality. A comprehensive understanding of these temporal trends and future trajectories is critical for developing effective cancer control policies. Data from the Global Burden of Disease Study 2021 were used to systematically evaluate age-standardized incidence rates (ASIRs), prevalence rates, mortality rates (ASMRs), and disability-adjusted life-year rates for gastric and colorectal cancers between 1990 and 2021. Temporal trends were assessed using joinpoint regression and ARIMA models. Decomposition analysis was performed to differentiate among the effects of population growth, aging, and epidemiological changes. Finally, trend-based projections of the global burden through 2050 were performed. Between 1990 and 2021, both ASIR and ASMR for gastric cancer declined globally, particularly in high Socio-demographic Index countries. Conversely, colorectal cancer demonstrated an increasing trend in ASIR and age-standardized prevalence rates, although ASMR and disability-adjusted life-year rates decreased. Countries with a high Socio-demographic Index exhibited a higher incidence of colorectal cancer but benefited from lower mortality, likely reflecting differences in healthcare capacity. Males experienced a consistently higher burden of both cancers. Trend-based projections suggest a continued decline in the burden of gastric cancer, whereas the incidence of colorectal cancer may remain relatively stable or increase modestly, with mortality continuing to decline. Despite declining mortality rates, gastric and colorectal cancers remain a substantial global health burden, with distinct epidemiological patterns. Enhancing early detection strategies, such as gastroscopy and colonoscopy, along with dietary modifications and Helicobacter pylori eradication in high-risk populations, may help mitigate the future disease burden and inform health policy interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.